SZECHENYI ISTVAN EGYETEM

Their core work

Széchenyi István University in Győr, Hungary, is a multidisciplinary university with growing strength in biomedical engineering, particularly 3D tissue models, nanofibrous scaffolds, and drug delivery systems. They also contribute to sustainable agriculture through algae-based biorefinery research and to digital infrastructure through HPC and big data projects. Their applied research bridges biomaterials science and pharmaceutical testing, with a focus on translating lab-scale tissue engineering into practical tools for drug development and toxicology screening.

What they specialise in

How they've shifted over time

In 2014–2018, Széchenyi István University pursued diverse topics including assistive devices for the visually impaired (Sound of Vision), algae biorefinery for agriculture (SABANA), HPC simulation infrastructure, and Danube basin environmental research. From 2019 onward, a clear pivot emerged toward biomedical tissue engineering — with iP-OSTEO and ActiTOX both centered on bioreactors, nanofibrous scaffolds, drug delivery, and 3D organotypic models. This shift suggests the university built internal capacity in biomaterials and pharmaceutical screening that now defines their research identity.

Széchenyi István is consolidating around biomedical engineering — expect future proposals in advanced drug screening, organ-on-chip platforms, and personalized medicine applications.

How they like to work

Széchenyi István University has never coordinated an H2020 project, always joining as a participant in medium-to-large consortia. With 381 unique partners across 35 countries, they operate as a broad connector rather than a repeat-partnership hub. Their participation style — modest funding shares in large international teams — suggests they contribute specialized expertise (particularly in biomaterials and simulation) without seeking project leadership overhead.

With 381 unique consortium partners spread across 35 countries, Széchenyi István has an unusually wide network for a mid-sized Hungarian university. Their partnerships span Western Europe, the Mediterranean, and beyond — reflecting diverse project topics from agriculture (Southern Europe focus in SABANA) to HPC infrastructure (pan-European).

What sets them apart

Among Hungarian universities in H2020, Széchenyi István stands out for its specific combination of biomaterials/tissue engineering expertise with computational simulation capacity — few regional universities bridge these two domains. Their location in Győr, Hungary's automotive and engineering hub, gives them strong industry connections that complement their academic research. For consortium builders, they offer a reliable Central European partner with hands-on experience in electrospinning, 3D bioprinting, and microfluidic systems at competitive cost.

Highlights from their portfolio

• SABANA
  Their largest H2020 project (EUR 540K) in sustainable algae biorefinery — a 5-year effort connecting marine biology with agricultural applications like biopesticides and aquafeed.
• iP-OSTEO
  Combines iPSC technology with nanofibrous scaffolds and bioreactors for musculoskeletal disease — represents their clearest biomedical specialization and MSCA-RISE mobility.
• HiDALGO
  Their second-largest project (EUR 506K) in HPC/big data for global systems simulation, showing computational capacity beyond their biomedical focus.